Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency

Study Title

Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)

Teva Identifier

TV1106-IMM-30022 | 2014-002736-13

ClinicalTrials.gov Identifier

NCT02410356

Study Status

Terminated

Trial Condition(s)

Growth Hormone Deficiency

Interventions

Drug: TV-1106 | Drug: dGH

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
muscle icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years and older

Trial Duration

April 30, 2015 - April 30, 2016

Phase

Phase 3

Study Type

Interventional